Market revenue in 2023 | USD 37.3 million |
Market revenue in 2030 | USD 97.7 million |
Growth rate | 14.7% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 25.74% in 2023. Horizon Databook has segmented the France research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The focus of biotechnology investors in France has shifted towards researching the potential applications of research-grade proteins over the years. For instance, in March 2023, Iktos, a French startup focusing on AI for innovative drug discovery, has secured €15.5 million (USD 16.54 million) in Series A funding.
This investment round was coled by M Ventures & Debiopharm Innovation Fund, both new investors, and included participation from Omnes Capital, a supporter of Gourmey, The Exploration Company, and Capsule Corp Labs.
Moreover, in June 2020, Sanofi invested around USD 679.4 million in two French sites to increase vaccine research in the region. Thus, the growing investments by the leading organizations are anticipated to boost the market size for the research-grade proteins in France over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the France research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into France research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account